Rucaparib vs docetaxel (DTX) or second-generation androgen receptor pathway inhibitor (ARPI) therapy for patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) with BRCA mutations based on Eastern Cooperative Oncology Group performance status (ECOG PS) in TRITON3.


Por: Reaume, MN, Fizazi, K, Bryce, AH, Chowdhury, S, Ryan, CJ, Villanueva, N, Caffo, O, Chakmakjian, CG, Ernst, DS, Feyerabend, S, Font, A, Ganju, V, Kushnir, I, Hajdenberg, J, Madsen, CV, Borrow, J, Ong, V and Ostler, PJ

Publicada: 1 mar 2026
Resumen:


Filiaciones:
Reaume, MN:
 Ottawa Hosp Canc Ctr, Ottawa, ON, Canada

 Univ Ottawa, Ottawa, ON, Canada

Fizazi, K:
 Univ Paris Saclay, Inst Gustave Roussy, Ctr Oscar Lambret, Lille, France

Bryce, AH:
 Mayo Clin Arizona, Phoenix, AZ USA

Chowdhury, S:
 Guys & St Thomas NHS Fdn Trust, London, England

Ryan, CJ:
 Univ Minnesota, Minneapolis, MN USA

Villanueva, N:
 Hosp Univ Cent Asturias, Oviedo, Spain

Caffo, O:
 Santa Chiara Hosp, Trento, Italy

Chakmakjian, CG:
 Texas Oncol, Waco, TX USA

Ernst, DS:
 Western Univ, London, ON, Canada

Feyerabend, S:
 Studienpraxis Urol, Nurtingen, Germany

:
 Hosp Badalona Germans Trias & Pujol, Inst Catala Oncol, Badalona, Spain

Ganju, V:
 Peninsula & South East Oncol Med, Frankston, Vic, Australia

Kushnir, I:
 Tel Aviv Univ, Tel Aviv, Israel

Hajdenberg, J:
 Univ Florida, Hlth Canc Ctr, Orlando, FL USA

Madsen, CV:
 Univ Hosp Southern Denmark, Vejle, Denmark

Borrow, J:
 Pharma, New York, NY USA

Ong, V:
 Pharma, New York, NY USA

Ostler, PJ:
 Mt Vernon Canc Ctr, Northwood, England
ISSN: 0732183X





JOURNAL OF CLINICAL ONCOLOGY
Editorial
American Society of Clinical Oncology, 2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA, Estados Unidos America
Tipo de documento: Meeting Abstract
Volumen: 44 Número: 7_SUPPL
Páginas: 46-46
WOS Id: 001729941200017

MÉTRICAS